Olanzapine in the treatment of bipolar disorder

Psychiatrische Praxis
Stephanie Krüger

Abstract

Olanzapin is an atypical antipsychotic drug, which is approved for use in acute mania and in the prophylaxis of bipolar disorder. There are eight double-blind, placebo-controlled studies, which show its efficacy in the treatment of acute mania, five, which document its efficacy in the long-term treatment of bipolar disorder and one that shows its use in bipolar depression. The following overview presents and critically evaluates these studies. Quality of life aspects on olanzapine treatment and the safety profile of the drug will also be discussed.

Related Concepts

Related Feeds

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
Peter SchmidtUrsula Reitberger
Medicinski Arhiv
Marijo VrdoljakSladana Strkalj Ivezić
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
G I KoliaskinaM A Morozova
© 2021 Meta ULC. All rights reserved